Depressive symptoms during the first month of chemotherapy and survival in patients with hematological malignancies: A prospective cohort study.
Takaaki HasegawaToru OkuyamaMegumi UchidaSayo AikiFuminobu ImaiMasahiro NishiokaNana SuzukiShinsuke IidaHirokazu KomatsuShigeru KusumotoMasaki RiSatoshi OsagaTatsuo AkechiPublished in: Psycho-oncology (2019)
Among patients with mature lymphoid malignancy, the group with depression at baseline had a poorer survival, both in the group that remained depressive and the group that recovered from depressive symptoms.